- Investing | July 11, 2012
Has Affymetrix Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
- Investing | July 09, 2012
Why Sequenom's Sinking in 2012
Volatility hasn't produced lasting gains this year.
- Investing | June 27, 2012
How the Obamacare Verdict Will Affect the Life Sciences Sector
A big verdict bears big implications for life science stocks this week.
- Investing | June 26, 2012
Genomic Health: Bright Spot in a Tough Market
- Investing | June 16, 2012
Analysts Debate: Is Life Technologies a Top Stock?
Examining different perspectives can help you become a better investor.
- Investing | May 29, 2012
3 Stocks for Biotech's Future
- High-Growth Investing | April 25, 2012
Buy, Sell, or Hold: Sequenom
$1,000 genetic sequencing bodes well for this stock.
- High-Growth Investing | April 20, 2012
This Takeover Is Off the Table. Maybe.
Has Roche walked away from Illumina, or is it bluffing?
- High-Growth Investing | April 13, 2012
It's Time to Start Buying Into the Next Bubble
This revolutionary technology will change the world... and your portfolio.
- Investing | April 12, 2012
You, Sir, Are No Apple (but We Still Want to Buy You)
Roche insults Illumina, Lloyd Bentsen-style.